Business Description
Universal Ibogaine Inc
NAICS : 541713
SIC : 3741
ISIN : CA69379R1082
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.17 | |||||
Equity-to-Asset | 0.29 | |||||
Debt-to-Equity | 1.78 | |||||
Debt-to-EBITDA | -2.55 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -7 | |||||
Beneish M-Score | -0.64 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -26 | |||||
3-Year EPS without NRI Growth Rate | -21.6 | |||||
3-Year FCF Growth Rate | 7.2 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 60.72 | |||||
9-Day RSI | 56.75 | |||||
14-Day RSI | 54.91 | |||||
12-1 Month Momentum % | 50 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.65 | |||||
Quick Ratio | 0.65 | |||||
Cash Ratio | 0.42 | |||||
Days Sales Outstanding | 35.74 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -158 | |||||
Shareholder Yield % | -63.49 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -34.86 | |||||
Net Margin % | -66.94 | |||||
FCF Margin % | -35.25 | |||||
ROE % | -87.53 | |||||
ROA % | -28.05 | |||||
ROIC % | -13.33 | |||||
ROC (Joel Greenblatt) % | -38.97 | |||||
ROCE % | -37.92 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.37 | |||||
PB Ratio | 3 | |||||
Price-to-Tangible-Book | 1.5 | |||||
EV-to-EBIT | -4.88 | |||||
EV-to-EBITDA | -6.38 | |||||
EV-to-Revenue | 2.97 | |||||
EV-to-FCF | -6.55 | |||||
Earnings Yield (Greenblatt) % | -20.51 | |||||
FCF Yield % | -17.76 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Universal Ibogaine Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | 2.332 | ||
EPS (TTM) (C$) | -0.005 | ||
Beta | 5.02 | ||
Volatility % | 188.89 | ||
14-Day RSI | 54.91 | ||
14-Day ATR (C$) | 0.002712 | ||
20-Day SMA (C$) | 0.0135 | ||
12-1 Month Momentum % | 50 | ||
52-Week Range (C$) | 0.005 - 0.03 | ||
Shares Outstanding (Mil) | 308.61 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Universal Ibogaine Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Universal Ibogaine Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Universal Ibogaine Inc Frequently Asked Questions
What is Universal Ibogaine Inc(TSXV:IBO)'s stock price today?
When is next earnings date of Universal Ibogaine Inc(TSXV:IBO)?
Does Universal Ibogaine Inc(TSXV:IBO) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |